Loading...
XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer
The epidermal growth factor receptor (EGFR) and the insulin-like growth factor-1 receptor (IGF-1R) play critical roles in tumor growth, providing a strong rationale for the combined inhibition of IGF-1R and EGFR signaling in cancer therapy. We describe the design, affinity maturation, in vitro and i...
Na minha lista:
Udgivet i: | MAbs |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Taylor & Francis
2016
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4966845/ https://ncbi.nlm.nih.gov/pubmed/26984378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2016.1160989 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|